Zdrowie i gospodarka · 29/08/2017

FDA Announces Generic Drug User Fee Rates for Fiscal Year 2018

The US Food and Drug Administration (FDA) has published the fiscal year 2018 rates for Generic Drug User Fee Amendments (GDUFA II) fees, which cover fees for abbreviated new drug applications, drug master files, and other generic drug-related activities.